Title: Rational design of new antituberculosis agents: receptor-independent four-dimensional quantitative structure-activity relationship analysis of a set of isoniazid derivatives.
Journal: Journal of medicinal chemistry 20040715
1306738-80-6
42596-58-7
69835-75-2
176655-55-3 | Ritonavir Metabolite | AA0024Q3 | MFCD09840395
177034-25-2 | 2,4-Difluoro-5-methoxybenzaldehyde | AA002504 | MFCD24539280
1775-27-5 | 1H-Inden-1-one, 2-bromo-2,3-dihydro- | AA0025A9 | MFCD00041030
177947-96-5 | 1-Boc-3-azetidinecarboxaldehyde | AA0025K4 | MFCD06656142
17826-04-9 | 6-Bromoindole-3-carboxaldehyde | AA0025TH | MFCD00792689
178603-78-6 | L-Alaninamide, N-acetyl-L-tyrosyl-L-valyl-N-[(1S)-1-(carboxymethyl)-3-chloro-2-oxopropyl]- | AA002648 | MFCD00237124
178931-63-0 | 5,5''-Bis(trimethylstannyl)-2,2':5',2''-terthiophene | AA0026EX | MFCD30489177
179251-57-1 | 2-Bromo-5-methoxybenzene-1-sulfonyl chloride | AA0026TH | MFCD09880303
17963-32-5 | Silane, trichloro(11-chloroundecyl)- | AA00273C | MFCD11046082
31763-59-4 | 2-Propenoic acid, 2-methyl-, 3,3,4,4,5,5,6,6,6-nonafluorohexyl ester, homopolymer | AA01X49W | MFCD00236094